介入放射学杂志
介入放射學雜誌
개입방사학잡지
JOURNAL OF INTERVENTIONAL RADIOLOGY
2014年
10期
853-856
,共4页
肖云彬%陈智%黄希勇%王祥%杨舟
肖雲彬%陳智%黃希勇%王祥%楊舟
초운빈%진지%황희용%왕상%양주
冠状动脉瘘%国产动脉导管未闭封堵器
冠狀動脈瘺%國產動脈導管未閉封堵器
관상동맥루%국산동맥도관미폐봉도기
coronary artery fistula%domestic patent ductus arteriosus occluder
目的:评价动脉导管未闭(PDA)封堵器在小儿冠状动脉瘘介入封堵治疗的近中期疗效。方法回顾性分析2008年1月-2013年5月在我院采用PDA封堵器进行冠状动脉瘘介入封堵治疗患儿的临床资料及术后随访资料。结果本组8例患儿,年龄(4.1±3.8)岁,右冠状动脉起源5例,左冠状动脉起源3例,分流入右心房、右心室各4例。所有患儿均成功进行封堵治疗,术后随访(2.2±1.2)年,无介入治疗相关并发症、心肌缺血表现。结论 PDA封堵器应用于冠状动脉瘘介入封堵治疗近中期疗效满意。
目的:評價動脈導管未閉(PDA)封堵器在小兒冠狀動脈瘺介入封堵治療的近中期療效。方法迴顧性分析2008年1月-2013年5月在我院採用PDA封堵器進行冠狀動脈瘺介入封堵治療患兒的臨床資料及術後隨訪資料。結果本組8例患兒,年齡(4.1±3.8)歲,右冠狀動脈起源5例,左冠狀動脈起源3例,分流入右心房、右心室各4例。所有患兒均成功進行封堵治療,術後隨訪(2.2±1.2)年,無介入治療相關併髮癥、心肌缺血錶現。結論 PDA封堵器應用于冠狀動脈瘺介入封堵治療近中期療效滿意。
목적:평개동맥도관미폐(PDA)봉도기재소인관상동맥루개입봉도치료적근중기료효。방법회고성분석2008년1월-2013년5월재아원채용PDA봉도기진행관상동맥루개입봉도치료환인적림상자료급술후수방자료。결과본조8례환인,년령(4.1±3.8)세,우관상동맥기원5례,좌관상동맥기원3례,분류입우심방、우심실각4례。소유환인균성공진행봉도치료,술후수방(2.2±1.2)년,무개입치료상관병발증、심기결혈표현。결론 PDA봉도기응용우관상동맥루개입봉도치료근중기료효만의。
Objective To assess the clinical short-term to mid-term efficacy of transcatheter closure of coronary artery fistula by using patent ductus arteriosus occluder in pediatric patients. Methods During the period from Jan. 2008 to May 2013 at authors’ hospital, transcatheter closure of coronary artery fistula using patent ductus arteriosus occluder was performed in 8 pediatric patients. The clinical data, including follow-up information, were retrospectively analyzed. Results A total of 8 pediatric patients with a mean age of (4.1 ± 3.8) years were enrolled in this study. The fistula originated from the right coronary artery in five cases and from the left coronary artery in three cases. The blood flow shunted to the right atrium (n=4) or to the right ventricle (n = 4). Obstruction of the fistula was successfully accomplished in all patients. All patients were followed up for (2.2 ± 1.2) years. No procedure-related complications or cardiac ischemia occurred. Conclusion For the treatment of coronary artery fistula in pediatric patients, the use of domestic patent ductus arteriosus occluder is safe and effective with satisfactory short-term to mid-term clinical efficacy.